TC BioPharm Ltd
NASDAQ:TCBP
Cash Flow Statement
Cash Flow Statement
TC BioPharm Ltd
| Jun-2021 | Sep-2021 | Dec-2021 | Jun-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Mar-2024 | ||
|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||
| Net Income |
(6)
|
(12)
|
(15)
|
0
|
(3)
|
(4)
|
(3)
|
(3)
|
|
| Depreciation & Amortization |
1
|
1
|
1
|
0
|
1
|
1
|
1
|
(0)
|
|
| Stock-Based Compensation |
0
|
1
|
0
|
0
|
1
|
1
|
1
|
1
|
|
| Other Non-Cash Items |
1
|
6
|
8
|
0
|
(8)
|
(10)
|
(15)
|
4
|
|
| Cash Taxes Paid |
(1)
|
(1)
|
(1)
|
0
|
(1)
|
0
|
0
|
0
|
|
| Cash Interest Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Change in Working Capital |
0
|
1
|
1
|
(9)
|
(5)
|
(4)
|
5
|
(0)
|
|
| Cash from Operating Activities |
(4)
N/A
|
(5)
-10%
|
(6)
-23%
|
(13)
-125%
|
(15)
-16%
|
(17)
-20%
|
(12)
+30%
|
1
N/A
|
|
| Investing Cash Flow | |||||||||
| Capital Expenditures |
(0)
|
(0)
|
(0)
|
0
|
(0)
|
(1)
|
(1)
|
0
|
|
| Other Items |
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
|
| Cash from Investing Activities |
(0)
N/A
|
(0)
+7%
|
(0)
N/A
|
(0)
-14%
|
(0)
-94%
|
(0)
-47%
|
(0)
+1%
|
0
N/A
|
|
| Financing Cash Flow | |||||||||
| Net Issuance of Common Stock |
4
|
0
|
0
|
0
|
3
|
5
|
4
|
(0)
|
|
| Net Issuance of Debt |
1
|
4
|
6
|
0
|
(3)
|
0
|
(4)
|
0
|
|
| Other |
(0)
|
(0)
|
(0)
|
13
|
18
|
20
|
8
|
(3)
|
|
| Cash from Financing Activities |
5
N/A
|
4
-20%
|
7
+72%
|
18
+178%
|
18
-1%
|
22
+22%
|
9
-60%
|
(3)
N/A
|
|
| Change in Cash | |||||||||
| Effect of Foreign Exchange Rates |
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
|
| Net Change in Cash |
0
N/A
|
(1)
N/A
|
1
N/A
|
6
+589%
|
3
-43%
|
4
+22%
|
(4)
N/A
|
(2)
+42%
|
|
| Free Cash Flow | |||||||||
| Free Cash Flow |
(4)
N/A
|
(5)
-9%
|
(6)
-22%
|
(13)
-119%
|
(15)
-19%
|
(18)
-21%
|
(13)
+29%
|
1
N/A
|
|